🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Madeline Rodríguez-Valentín

University of South Florida

ORCID: 0000-0003-1920-7522

Also affiliated with Moffitt Cancer Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients”.

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007288

N/A

0.542DataRank · unranked

36 citations

Jamie K. Teer, Xiaoqing Yu, Holly Branthoover, Sebastian Snedal, Madeline Rodríguez-Valentín +20 more

The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells

Viruses(2023)10.3390/v15030804

N/A

0DataRank · unranked

6 citations

Madeline Rodríguez-Valentín, Nawal M. Boukli, Eduardo Alvarez-Rivera

Expansion of tumor-infiltrating and marrow-infiltrating lymphocytes from pediatric malignant solid tumors

Cytotherapy(2024)10.1016/j.jcyt.2024.08.002

N/A

0DataRank · unranked

5 citations

Madeline Rodríguez-Valentín, Jonathan A. Hensel, Alex Alfaro, Christopher W Snyder, Odion Binitie +5 more